10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 150 filers reported holding 10X GENOMICS INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 2.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,834,064 | -6.4% | 92,947 | +26.7% | 0.48% | -14.2% |
Q2 2023 | $4,097,874 | -0.1% | 73,386 | -0.1% | 0.56% | +1.4% |
Q1 2023 | $4,100,286 | -0.2% | 73,495 | +166.5% | 0.56% | +77.6% |
Q4 2021 | $4,107,000 | -21.2% | 27,573 | -23.0% | 0.31% | -16.3% |
Q3 2021 | $5,212,000 | -7.9% | 35,800 | +23.9% | 0.37% | 0.0% |
Q2 2021 | $5,659,000 | -13.6% | 28,900 | -20.2% | 0.37% | -20.6% |
Q1 2021 | $6,552,000 | +9.1% | 36,200 | -14.6% | 0.47% | +16.0% |
Q4 2020 | $6,004,000 | -26.5% | 42,401 | -35.3% | 0.41% | -24.7% |
Q3 2020 | $8,169,000 | +13.1% | 65,522 | -19.0% | 0.54% | +9.6% |
Q2 2020 | $7,225,000 | – | 80,900 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |